ARTV
NASDAQ · Biotechnology
Artiva Biotherapeutics Inc
$4.01
+0.05 (+1.26%)
Open$4.00
Previous Close$3.96
Day High$4.04
Day Low$3.91
52W High$14.53
52W Low$2.96
Volume—
Avg Volume1.03M
Market Cap198.22M
P/E Ratio—
EPS$-3.43
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+103.0% upside
Current
$4.01
$4.01
Target
$8.14
$8.14
$7.28
$8.14 avg
$10.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 567.1K | 1.13M | 14.43M |
| Net Income | -147,662,558 | -265,527,077 | -2,421,627 |
| Profit Margin | -26,045.0% | -24,742.8% | -16.8% |
| EBITDA | -154,251,730 | -292,785,501 | -2,990,686 |
| Free Cash Flow | — | — | -1,604,262 |
| Rev Growth | -50.0% | -50.0% | +14.0% |
| Debt/Equity | 0.00 | 0.00 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $469.15 | +0.75% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $542.98 | +0.81% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $959.96 | +0.47% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $161.38 | -2.22% | 7.7 | 20.98B |